AUPH logo

Aurinia Pharmaceuticals Inc. (AUPH)

Profile

Full Name

Aurinia Pharmaceuticals Inc.

Ticker

NASDAQ: AUPH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

September 3, 2014

Indexes

Not included

Website

http://www.auriniapharma.com

Employees

130

Key Details

Price

$9.19(+3.49%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$235.13M(+33.97% YoY)

Annual EPS

$0.04(+107.41% YoY)

PE ratio

32.82

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $9.19
    AUPH price is $9.19

    30-Day Relative Volume

    1.30
    AUPH 30-day relative volume is 1.30

    Price Performance

    Price Most recent change

    +3.49%
    AUPH price was up +3.49% on Jul 23, 2025

    Price YTD change

    +2.34%
    AUPH price is up +2.34% since January 1st

    Price 1-year change

    +65.29%
    AUPH price is up +65.29% year-on-year

    Price 3-year change

    -11.38%
    AUPH price is down -11.38% over the past 3 years

    Price Range

    Price All-time high

    $33.97
    AUPH price is currently -72.95% below its historical high of $33.97

    Price 3-year low

    $4.07
    AUPH price is currently +125.80% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.24B
    AUPH market capitalization is $1.24 billion

    Market cap 3-year change

    -15.62%
    AUPH market capitalization is down -15.62% over the past 3 years

    Market cap All-time high

    $4.29B
    AUPH market capitalization is currently -71.03% below its historical high of $4.29 billion

    Market cap sector rank

    76.65%
    AUPH market capitalization is higher than 76.65% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -5.51%
    AUPH shares outstanding is down -5.51% year-on-year

    Shares Outstanding 3-Year Change

    -4.78%
    AUPH shares outstanding is down -4.78% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.73
    AUPH beta is 0.73

    200-day SMA

    $8.13
    AUPH price is currently +13.05% above its 200-day simple moving average

    50-day SMA

    $8.21
    AUPH price is currently +11.92% above its 50-day simple moving average

    RSI

    62.68
    AUPH 14-day relative strength index is 62.68

    Volume

    1.30
    AUPH 30-day relative volume is 1.30

    ATR

    $0.39
    AUPH average true range is $0.39

    10-day Historical Volatility

    51.73%
    AUPH 10-day historical volatility is 51.73%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $235.13M
    AUPH annual revenue is $235.13 million

    Revenue Analysts estimate

    $258.98M
    AUPH annual revenue is currently -9.21% lower than the consensus analysts' forecast

    Revenue 1-year change

    +33.97%
    AUPH annual revenue is up +33.97% year-on-year

    Revenue Sector rank

    65.94%
    AUPH annual revenue is higher than 65.94% of companies in Healthcare sector

    EPS

    EPS

    $0.04
    AUPH annual earnings per share is $0.04

    EPS Analysts estimate

    $0.59
    AUPH annual earnings per share is currently -93.17% lower than the consensus analysts' forecast

    EPS 1-year change

    +107.41%
    AUPH annual earnings per share is up +107.41% year-on-year

    EPS Sector rank

    82.39%
    AUPH annual earnings per share is higher than 82.39% of companies in Healthcare sector

    Profit

    Gross profit

    $206.88M
    AUPH annual gross profit is $206.88 million

    Gross margin

    87.99%
    AUPH annual gross profit margin is 87.99%

    Operating profit

    $18.42M
    AUPH annual operating income is $18.42 million

    Operating margin

    7.83%
    AUPH annual operating profit margin is 7.83%

    Net income

    $5.75M
    AUPH annual net profit is $5.75 million

    Net margin

    2.45%
    AUPH annual net profit margin is 2.45%

    Expenses

    Total expenses

    $216.71M
    AUPH annual total expenses is $216.71 million

    Operating expenses

    $188.47M
    AUPH annual total operating expenses is $188.47 million

    Cost of goods sold

    $28.25M
    AUPH annual cost of goods sold is $28.25 million

    Selling, general & administrative expenses

    $172.03M
    AUPH annual SGA is $172.03 million

    Depreciation and amortization

    $19.45M
    AUPH annual depreciation & amortization is $19.45 million

    Interest expense

    $4.83M
    AUPH annual interest expense is $4.83 million

    Income tax

    $1.70M
    AUPH annual income tax is $1.70 million

    EBIT & EBITDA

    EBIT

    $12.28M
    AUPH annual earnings before interest & taxes is $12.28 million

    EBITDA

    $31.73M
    AUPH annual EBITDA is $31.73 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $550.64M
    AUPH annual total assets is $550.64 million

    Non current assets

    $104.05M
    AUPH annual long term assets is $104.05 million

    Current assets

    $446.60M
    AUPH annual total current assets is $446.60 million

    Cash and cash equivalents

    $83.43M
    AUPH annual cash & cash equivalents is $83.43 million

    Accounts receivable

    $36.54M
    AUPH annual accounts receivable is $36.54 million

    Inventory

    $39.23M
    AUPH annual inventory is $39.23 million

    Liabilities

    Total liabilities

    $173.17M
    AUPH annual total liabilities is $173.17 million

    Long term liabilities

    $75.40M
    AUPH annual total long term liabilities is $75.40 million

    Current liabilities

    $97.76M
    AUPH annual total current liabilities is $97.76 million

    Accounts payable

    $5.19M
    AUPH annual accounts payable is $5.19 million

    Debt

    Total debt

    $79.37M
    AUPH annual total debt is $79.37 million

    Total debt 1-year change

    -18.69%
    AUPH annual total debt is down -18.69% year-on-year

    Long term debt

    $64.30M
    AUPH annual long term debt is $64.30 million

    Short term debt

    $15.07M
    AUPH annual short term debt is $15.07 million

    Equity & Capital

    Shareholders equity

    $377.48M
    AUPH annual stockholders equity is $377.48 million

    Book value

    $377.48M
    AUPH annual book value is $377.48 million

    Retained earnings

    -$936.57M
    AUPH annual retained earnings is -$936.57 million

    Working capital

    $348.83M
    AUPH annual working capital is $348.83 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $44.39M
    AUPH annual cash flow from operations is $44.39 million

    Cash from operations 1-year change

    +232.66%
    AUPH annual cash flow from operations is up +232.66% year-on-year

    Cash from investing

    $39.26M
    AUPH annual cash flow from investing activities is $39.26 million

    Cash from investing 1-year change

    +685.48%
    AUPH annual cash flow from investing activities is up +685.48% year-on-year

    Cash from financing

    -$49.09M
    AUPH annual cash flow from financing activities is -$49.09 million

    Cash from financing 1-year change

    -856.96%
    AUPH annual cash flow from financing activities is down -856.96% year-on-year

    CAPEX

    CAPEX

    $281.00K
    AUPH annual capital expenditures is $281.00 thousand

    CAPEX 1-year change

    -60.86%
    AUPH annual capital expenditures is down -60.86% year-on-year

    Free Cash Flow

    Free cash flow

    $44.11M
    AUPH annual free cash flow is $44.11 million

    Free cash flow 1-year change

    +229.05%
    AUPH annual free cash flow is up +229.05% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    87.99%
    AUPH annual gross profit margin is 87.99%

    Operating margin

    7.83%
    AUPH annual operating profit margin is 7.83%

    Net margin

    2.45%
    AUPH annual net profit margin is 2.45%

    ROA & ROE

    ROA

    1.05%
    AUPH annual return on assets is 1.05%

    ROE

    1.52%
    AUPH annual return on equity is 1.52%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    32.82
    AUPH price to earnings ratio is 32.82

    PE ratio Sector rank

    62.74%
    AUPH price to earnings ratio is higher than 62.74% of companies in Healthcare sector

    PB Ratio

    PB ratio

    3.55
    AUPH price to book ratio is 3.55

    PB ratio Sector rank

    70.89%
    AUPH price to book ratio is higher than 70.89% of companies in Healthcare sector

    PS Ratio

    PS ratio

    5.02
    AUPH price to sales ratio is 5.02

    PS ratio Sector rank

    61.55%
    AUPH price to sales ratio is higher than 61.55% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.25B
    AUPH enterprise value is $1.25 billion

    Enterprise value Sector rank

    75.56%
    AUPH enterprise value is higher than 75.56% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    19.02
    AUPH EV/EBITDA is 19.02

    EV/EBITDA Sector rank

    91.2%
    AUPH EV/EBITDA is higher than 91.2% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    4.57
    AUPH annual current ratio is 4.57

    Quick ratio

    4.17
    AUPH annual quick ratio is 4.17

    Leverage

    Debt to equity

    0.00
    AUPH annual debt to equity ratio is 0.00

    Interest coverage ratio

    2.54
    AUPH annual interest coverage ratio is 2.54

    Risk & Stability

    Piotroski F-Score

    9
    AUPH piotroski f-score is 9

    Altman Z-Score

    3.18
    AUPH altman z-score is 3.18

    Analyst ratings

    Recent major analysts updates

    Sep 16, 24 Cantor Fitzgerald
    Overweight
    Sep 9, 24 Cantor Fitzgerald
    Overweight
    Sep 6, 24 HC Wainwright & Co.
    Buy
    Mar 1, 24 HC Wainwright & Co.
    Buy
    Feb 23, 24 Cantor Fitzgerald
    Overweight
    Feb 22, 24 HC Wainwright & Co.
    Buy
    Feb 16, 24 RBC Capital
    Outperform
    Sep 22, 23 HC Wainwright & Co.
    Buy
    Aug 7, 23 HC Wainwright& Co.
    Buy
    Aug 7, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with AUPH included

    High Piotroski score stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Aurinia Pharmaceuticals Inc.?
    • Does Aurinia Pharmaceuticals Inc. pay dividends?
    • What sector is Aurinia Pharmaceuticals Inc. in?
    • What industry is Aurinia Pharmaceuticals Inc. in?
    • What country is Aurinia Pharmaceuticals Inc. based in?
    • When did Aurinia Pharmaceuticals Inc. go public?
    • Is Aurinia Pharmaceuticals Inc. in the S&P 500?
    • Is Aurinia Pharmaceuticals Inc. in the NASDAQ 100?
    • Is Aurinia Pharmaceuticals Inc. in the Dow Jones?
    • When was Aurinia Pharmaceuticals Inc.'s last earnings report?
    • When does Aurinia Pharmaceuticals Inc. report earnings?

    What is the ticker symbol for Aurinia Pharmaceuticals Inc.?

    The ticker symbol for Aurinia Pharmaceuticals Inc. is NASDAQ:AUPH

    Does Aurinia Pharmaceuticals Inc. pay dividends?

    No, Aurinia Pharmaceuticals Inc. does not pay dividends

    What sector is Aurinia Pharmaceuticals Inc. in?

    Aurinia Pharmaceuticals Inc. is in the Healthcare sector

    What industry is Aurinia Pharmaceuticals Inc. in?

    Aurinia Pharmaceuticals Inc. is in the Biotechnology industry

    What country is Aurinia Pharmaceuticals Inc. based in?

    Aurinia Pharmaceuticals Inc. is headquartered in Canada

    When did Aurinia Pharmaceuticals Inc. go public?

    Aurinia Pharmaceuticals Inc.'s initial public offering (IPO) was on September 3, 2014

    Is Aurinia Pharmaceuticals Inc. in the S&P 500?

    No, Aurinia Pharmaceuticals Inc. is not included in the S&P 500 index

    Is Aurinia Pharmaceuticals Inc. in the NASDAQ 100?

    No, Aurinia Pharmaceuticals Inc. is not included in the NASDAQ 100 index

    Is Aurinia Pharmaceuticals Inc. in the Dow Jones?

    No, Aurinia Pharmaceuticals Inc. is not included in the Dow Jones index

    When was Aurinia Pharmaceuticals Inc.'s last earnings report?

    Aurinia Pharmaceuticals Inc.'s most recent earnings report was on May 12, 2025

    When does Aurinia Pharmaceuticals Inc. report earnings?

    The next expected earnings date for Aurinia Pharmaceuticals Inc. is July 31, 2025
    On this page